CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
2020 ◽
Vol 24
(13)
◽
pp. 7239-7253
◽
2011 ◽
Vol 13
(6)
◽
pp. 458-467
◽
2015 ◽
Vol 7
(6)
◽
pp. 388-395
◽
2013 ◽
Vol 9
(4)
◽
pp. 547-555
◽
Keyword(s):
2012 ◽
Vol 54
(4)
◽
pp. 683-687
◽
Keyword(s):
Keyword(s):